Fig. 1
From: Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis

Study selection process
From: Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis
Study selection process